From Casetext: Smarter Legal Research

Lilak v. AstraZenca Pharm.-US Inc.

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLORADO
Aug 21, 2012
Civil Action No. 12-cv-00031-PAB-MJW (D. Colo. Aug. 21, 2012)

Opinion

Civil Action No. 12-cv-00031-PAB-MJW

08-21-2012

SAFDAR LILAK, Plaintiff(s), v. ASTRAZENCA PHARMACEUTICAL-US INC., CORPORATION, Defendant(s).


MINUTE ORDER

Entered by Magistrate Judge Michael J. Watanabe

It is hereby ORDERED that plaintiff's "After Scheduling Conference, of March 6th, 2012 & 07/23/12 Rule D.C.Colo.LCivR16.1/16.2 Flurry of Motions & Objections to MJW Recommendation Plaintiff Proposes Following" (Docket No. 40), insofar as it can be considered a motion, is DENIED. Defendant's Motion to Dismiss (Docket No. 6) is pending, this court having recommended dismissal of plaintiff's complaint (Docket No. 33). Accordingly, the court will not order ADR and defendant is not obligated to answer plaintiff's complaint at this time.


Summaries of

Lilak v. AstraZenca Pharm.-US Inc.

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLORADO
Aug 21, 2012
Civil Action No. 12-cv-00031-PAB-MJW (D. Colo. Aug. 21, 2012)
Case details for

Lilak v. AstraZenca Pharm.-US Inc.

Case Details

Full title:SAFDAR LILAK, Plaintiff(s), v. ASTRAZENCA PHARMACEUTICAL-US INC.…

Court:UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLORADO

Date published: Aug 21, 2012

Citations

Civil Action No. 12-cv-00031-PAB-MJW (D. Colo. Aug. 21, 2012)